| Product Code: ETC8679532 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Norway`s subcutaneous drug delivery devices import market in 2024 saw significant contributions from top exporting countries like USA, Ireland, Costa Rica, Denmark, and Mexico. The market displayed low concentration with a Herfindahl-Hirschman Index (HHI) remaining stable. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 9.04%, indicating a healthy market expansion. Additionally, the growth rate from 2023 to 2024 stood at 5.67%, underlining continued momentum in the importation of subcutaneous drug delivery devices in Norway.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Subcutaneous Drug Delivery Devices Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Norway Subcutaneous Drug Delivery Devices Market - Industry Life Cycle |
3.4 Norway Subcutaneous Drug Delivery Devices Market - Porter's Five Forces |
3.5 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Norway Subcutaneous Drug Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Norway, leading to a higher demand for subcutaneous drug delivery devices. |
4.2.2 Rising adoption of self-administration of drugs by patients due to convenience and cost-effectiveness. |
4.2.3 Technological advancements in subcutaneous drug delivery devices, offering improved safety, accuracy, and ease of use. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of subcutaneous drug delivery devices in Norway may hinder market growth. |
4.3.2 Limited awareness and education among healthcare professionals and patients about the benefits and proper usage of subcutaneous drug delivery devices. |
5 Norway Subcutaneous Drug Delivery Devices Market Trends |
6 Norway Subcutaneous Drug Delivery Devices Market, By Types |
6.1 Norway Subcutaneous Drug Delivery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.4 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Pen injectors, 2021- 2031F |
6.1.5 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Auto-injectors, 2021- 2031F |
6.1.6 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Wearable injectors, 2021- 2031F |
6.1.7 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Needle-free injectors, 2021- 2031F |
6.2 Norway Subcutaneous Drug Delivery Devices Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.2.3 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.2.4 Norway Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 Norway Subcutaneous Drug Delivery Devices Market Import-Export Trade Statistics |
7.1 Norway Subcutaneous Drug Delivery Devices Market Export to Major Countries |
7.2 Norway Subcutaneous Drug Delivery Devices Market Imports from Major Countries |
8 Norway Subcutaneous Drug Delivery Devices Market Key Performance Indicators |
8.1 Patient adherence rate to subcutaneous drug therapy. |
8.2 Number of new product launches and technological innovations in the subcutaneous drug delivery devices market. |
8.3 Percentage increase in prescriptions for drugs administered via subcutaneous delivery. |
8.4 Healthcare provider training and certification rates on the use of subcutaneous drug delivery devices. |
8.5 Rate of hospital readmissions related to subcutaneous drug therapy complications. |
9 Norway Subcutaneous Drug Delivery Devices Market - Opportunity Assessment |
9.1 Norway Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Norway Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Norway Subcutaneous Drug Delivery Devices Market - Competitive Landscape |
10.1 Norway Subcutaneous Drug Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Norway Subcutaneous Drug Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |